Cell Therapy Technologies Global Market Report 2022 by The Business Research Company is the most comprehensive report available on the market, being wide-ranging both in terms of chronology and geography. It covers the historic period – 2016-2021, and the forecast period – 2022-2026, with additional forecasts for 2026-2031. The report helps gain a truly global perspective as it covers 60 geographies, focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
TBRC’s market report includes a chapter on the COVID-19 impact on the cell therapy technologies industry, which gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market and how companies can strategize to bounce back from it. With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected cell therapy technologies market growth numbers from 2022-2031.
Request a Sample of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp
The global cell therapy technologies market size is expected to grow from $2.96 billion in 2021 to $3.52 billion in 2022 at a compound annual growth rate (CAGR) of 19.0%. The growth in the market is mainly due to an increase in investments in cell therapies and the growth in research and development for cell therapy. The cell therapy technologies market is expected to reach $6.35 billion in 2026 at a CAGR of 15.9%.
View more on the report:
https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report
The Cell Therapy Technologies Global Market Report 2022-31 by The Business Research Company evaluates cell therapy technologies market size, growth rate, drivers, cell therapy technologies industry trends, and major companies.
The cell therapy technologies market segments in the report are:
1) By Product: Consumables, Equipment, Systems and Software
2) By Cell Type: T-Cells, Stem Cells, Other Cells
3) By Process: Cell Processing, Cell Preservation, Distribution, and Handling, Process Monitoring and Quality Control
4) By End User: Life Science Companies, Research Institutes
The table of contents in TBRC’s cell therapy technologies market report includes:
1. Executive Summary
2. Cell Therapy Technologies Market Characteristics
3. Cell Therapy Technologies Market Size And Growth
4. Cell Therapy Technologies Market Segmentation
5. Cell Therapy Technologies Market Regional And Country Analysis
...
26. Key Mergers And Acquisitions In The Cell Therapy Technologies Market
27. Cell Therapy Technologies Market Trends And Strategies
28. Cell Therapy Technologies Market Future Outlook and Potential Analysis
About The Business Research Company:
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.
Get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/
The study involved four major activities to estimate the current size of the cell therapy technologies market.
The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.
Both top-down and bottom-up approaches were employed to estimate the complete market size.Key Factors Driving Market Growth:The emerging economies such as Australia and China are expected to provide a wide range of growth opportunities for players in the market which is driven by their large and growing populations as well as increase in the number of clinical trials and investments in the field of personalized medicine in these countries.Revenue Growth Analysis:The cell therapy technologies market is projected to reach USD 5.6 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 14.4% from 2020 to 2025.COVID -19 Impact on the Cell Therapy Technologies Market :The outbreak of COVID-19 is expected to have a minimal or negligible negative impact on the cell therapy technologies market.
The rise in the incidences of COVID has led to an increase in the need for an efficient drug or vaccine for COVID, which could help in reducing the severity of the cases.
Precision medicine involves the selection of drugs wholly tailored to a patient based on disease condition and history.
Although this practice is expanding into all disease areas, oncology has seen the most progress.Precision medicine offers a new paradigm in oncology, where a patient receives personalized treatment.
According to the new market research report “Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell Type (Human Stem & Differentiated, Animal), Process Stages (Cell Processing, Distribution, Handling, QC), End User, and Region - Global Forecast to 2023", published by MarketsandMarkets™, The Cell Therapy Technologies Market is projected to reach USD 19.9 billion by 2023 from USD 10.2 billion in 2018, at a CAGR of 14.4%.
Factors such as rising governent investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are driving the growth of this market.To Get Sample Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978Rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are the key factors driving the growth of this market.
China, India, Japan, Korea, and Brazil are emerging markets for cell therapy instruments.These markets boast comparatively lenient standards and government regulations as opposed to developed markets in North America and the EU, and thus offer significant growth potential for providers.
However, the high cost of cell-based research and the low success rate is expected to restrain market growth to some extent during the forecast period.Browse and in-depth TOC on “Cell Therapy Technologies Market”75 - Tables30 - Figures116 - PagesKey Market PlayersKey players in this market include Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT (US), and Thermo Fisher Scientific (US).Thermo Fisher was the largest player in the cell therapy technologies market in 2017.
In order to maintain its position in the market and further expand its product portfolio, the company focuses on the strategies of product launches, acquisitions, and expansions.
Merck holds the second position in the cell therapy technologies market.
Factors such as the growing awareness related to the therapeutic potency of stem cells in disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments for stem cell research, identification of new stem cell lines, and developments in infrastructure for stem cell banking and processing are propelling the growth of the global stem cell therapy market.The Stem Cell Therapy Market is expected to reach USD 161.8 million by 2022, growing at a CAGR of 11.0% during the forecast period.Product AnalysisProduct Matrix which gives a detailed comparison of the product portfolios of the top five companiesGeographical AnalysisFurther breakdown of the North American stem cell therapy market into the US and CanadaFurther breakdown of the European stem cell therapy market into the UK, Germany, France, and Rest of EuropeCompany InformationDetailed analysis and profiling of additional market players (Up to 5)Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48 On the basis of therapeutic application, the global stem cell therapy market is segmented into musculoskeletal disorders, wounds and injuries, cardiovascular diseases, surgeries, gastrointestinal diseases, and other applications.
This large share can be attributed to the rising availability of stem cell-based products for the treatment of musculoskeletal disorders, high prevalence of musculoskeletal disorders and bone & joint diseases, and growing patient preference for effective & early treatment strategies.On the basis of cell source, the global stem cell therapy market is divided into adipose derived MSCs; bone marrow derived MSCs, embryonic / cord blood SCs, and other cell sources.
The adipose derived MSCs segment was expected to account for the largest share of 59.1% in the global stem cell therapy market in 2017.
Furthermore, the bone marrow derived MSCs segment is expected to grow at highest CAGR of 12.1% during the forecast period.Read more (Stem Cell Therapy Market):-https://www.marketsandmarkets.com/PressReleases/stem-cells-market.aspThe Major Players in this Market:As of 2016, Osiris Therapeutics, Inc. (U.S.), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), Pharmicell Co., Ltd. (South Korea), Holostem Terapie Avanzate S.r.l.
(Italy), JCR Pharmaceuticals Co., Ltd. (Japan), NuVasive, Inc. (U.S.), RTI Surgical, Inc. (U.S.), and AlloSource (U.S.) were some of the key players operating in the global stem cell therapy market.
About MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.
